(Q38967981)

8 September 2017

1 reference

title

Cholinergic involvement in mental disorders (English)

1 reference

https://api.crossref.org/works/10.1016/0024-3205(78)90472-1

25 October 2022

author name string

K. L. Davis

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A27686

25 October 2022

P. A. Berger

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A27686

25 October 2022

L. E. Hollister

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A27686

25 October 2022

J. D. Barchas

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A27686

25 October 2022

language of work or name

English

0 references

publication date

1 June 1978

1 reference

8 September 2017

5 June 1978

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=27686

full work available at URL

25 October 2022

https://api.elsevier.com/content/article/PII:0024320578904721?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0024-3205(78)90472-1

https://api.elsevier.com/content/article/PII:0024320578904721?httpAccept=text/plain

25 October 2022

1 reference

https://api.crossref.org/works/10.1016/0024-3205(78)90472-1

25 October 2022

1 reference

8 September 2017

22

1 reference

8 September 2017

1865-1871

1 reference

8 September 2017

21

1 reference

Biogenic amines and affective disorders

8 September 2017

1

1 reference

https://api.crossref.org/works/10.1016/0024-3205(78)90472-1

Catecholamines and affective disorders revised: a critical assessment

25 October 2022

2

1 reference

https://api.crossref.org/works/10.1016/0024-3205(78)90472-1

The basis for amine hypotheses in affective disorders. A critical evaluation

25 October 2022

3

1 reference

https://api.crossref.org/works/10.1016/0024-3205(78)90472-1

Biochemical aspects of schizophrenia

25 October 2022

6

1 reference

https://api.crossref.org/works/10.1016/0024-3205(78)90472-1

25 October 2022

Biological Psychiatry

8

6

165

Friedhoff

1973

1 reference

https://api.crossref.org/works/10.1016/0024-3205(78)90472-1

A cholinergic-adrenergic hypothesis of mania and depression

25 October 2022

9

1 reference

https://api.crossref.org/works/10.1016/0024-3205(78)90472-1

The inhibition of the conditioned response and the counteraction of schizophrenia by muscarinic stimulation of the brain.

25 October 2022

11

1 reference

https://api.crossref.org/works/10.1016/0024-3205(78)90472-1

Comparative lucid intervals after amobarbital, CO2, and arecoline in the chronic schizophrenic

25 October 2022

12

1 reference

https://api.crossref.org/works/10.1016/0024-3205(78)90472-1

The effects of physostigmine in phenothiazine resistant chronic schizophrenic patients: preliminary observations.

25 October 2022

14

1 reference

https://api.crossref.org/works/10.1016/0024-3205(78)90472-1

Antagonistic Effects of Physostigmine and Methylphenidate in Man

25 October 2022

15

1 reference

https://api.crossref.org/works/10.1016/0024-3205(78)90472-1

The effects of diisopropylfluorophosphonate in schizophrenia and manic depressive psychosis

25 October 2022

16

1 reference

https://api.crossref.org/works/10.1016/0024-3205(78)90472-1

[Investigation about an influence of physostigmine on schizophrenic symptoms (author's transl)]

25 October 2022

17

1 reference

https://api.crossref.org/works/10.1016/0024-3205(78)90472-1

Increase in rat brain acetylcholine induced by choline or deanol

25 October 2022

22

1 reference

https://api.crossref.org/works/10.1016/0024-3205(78)90472-1

The source of choline for acetylcholine synthesis in brain

25 October 2022

25

1 reference

https://api.crossref.org/works/10.1016/0024-3205(78)90472-1

Choline in tardive dyskinesia and Huntington's disease

25 October 2022

26

1 reference

https://api.crossref.org/works/10.1016/0024-3205(78)90472-1

Reversal of some therapeutic effects of an antipsychotic agent by an antiparkinsonism drug

25 October 2022

28

1 reference

https://api.crossref.org/works/10.1016/0024-3205(78)90472-1

Effects of mode of management on plasma chlorpromazine in psychiatric patients.

25 October 2022

29

1 reference

https://api.crossref.org/works/10.1016/0024-3205(78)90472-1

An anatomy of schizophrenia?

25 October 2022

30

1 reference

https://api.crossref.org/works/10.1016/0024-3205(78)90472-1

Stereotaxic mapping of the monoamine pathways in the rat brain.

25 October 2022

31

1 reference

https://api.crossref.org/works/10.1016/0024-3205(78)90472-1

Mesencephalic dopamine neurons projecting to neocortex.

25 October 2022

32

1 reference

https://api.crossref.org/works/10.1016/0024-3205(78)90472-1

A pharmacologic analysis of Huntington's chorea

25 October 2022

33

1 reference

https://api.crossref.org/works/10.1016/0024-3205(78)90472-1

Effects of oxotremorine and physostigmine on the turnover of dopamine in the corpus striatum and the limbic system.

25 October 2022

35

1 reference

https://api.crossref.org/works/10.1016/0024-3205(78)90472-1

Dopamine turnover in the corpus striatum and the lumbic system after treatment with neuroleptic and anti-acetylcholine drugs.

25 October 2022

36

1 reference

https://api.crossref.org/works/10.1016/0024-3205(78)90472-1

The use of the push-pull cannula to estimate the dynamics of acetylcholine and catecholamines within various brain areas

25 October 2022

37

1 reference

https://api.crossref.org/works/10.1016/0024-3205(78)90472-1

Modification of the behavioural changes induced by amphetamine in the rat by lesions in the caudate nucleus, the caudate-putamen and globus pallidus

25 October 2022

38

1 reference

https://api.crossref.org/works/10.1016/0024-3205(78)90472-1

Pharmacology and physiology of stereotyped behavior

25 October 2022

39

1 reference

https://api.crossref.org/works/10.1016/0024-3205(78)90472-1

Role of the tuberculum olfactorium in stereotyped behaviour induced by apomorphine in the rat

25 October 2022

40

1 reference

https://api.crossref.org/works/10.1016/0024-3205(78)90472-1

Cholinergic antagonism of methylphenidate-induced stereotyped behavior

25 October 2022

41

1 reference

https://api.crossref.org/works/10.1016/0024-3205(78)90472-1

Cholinergic and anticholinergic influences on amphetamine-induced stereotyped behavior

25 October 2022

42

1 reference

https://api.crossref.org/works/10.1016/0024-3205(78)90472-1

Antischizophrenic drugs and brain cholinergic receptors. Affinity for muscarinic sites predicts extrapyramidal effects

25 October 2022

44

1 reference

https://api.crossref.org/works/10.1016/0024-3205(78)90472-1

Clozapine and the Dopamine Hypothesis of Schizophrenia, a Critical Appraisal

25 October 2022

45

1 reference

https://api.crossref.org/works/10.1016/0024-3205(78)90472-1

Effects of chemical stimulation of the mesolimbic dopamine system upon locomotor activity

25 October 2022

47

1 reference

https://api.crossref.org/works/10.1016/0024-3205(78)90472-1

Antagonism of the hyperactivity induced by dopamine applied intracerebrally to the nucleus accumbens septi by typical neuroleptics and by clozapine, sulpiride and thioridazine

25 October 2022

48

1 reference

https://api.crossref.org/works/10.1016/0024-3205(78)90472-1

Parasympathetic suppression of manic symptoms by physostigmine.

25 October 2022

49

1 reference

https://api.crossref.org/works/10.1016/0024-3205(78)90472-1

Depressive effects of physostigmine

25 October 2022

51

1 reference

https://api.crossref.org/works/10.1016/0024-3205(78)90472-1

Psychiatric sequelae of chronic exposure to organophosphorus insecticides

25 October 2022

53

1 reference

https://api.crossref.org/works/10.1016/0024-3205(78)90472-1

SOME BEHAVIORAL CHANGES IN MAN FOLLOWING ANTICHOLINESTERASE ADMINISTRATION

25 October 2022

54

1 reference

https://api.crossref.org/works/10.1016/0024-3205(78)90472-1

Physostigmine: effects on cognition and affect in normal subjects

25 October 2022

56

1 reference

https://api.crossref.org/works/10.1016/0024-3205(78)90472-1

Depression associated with oral choline

25 October 2022

57

1 reference

https://api.crossref.org/works/10.1016/0024-3205(78)90472-1

Mental depression in hypertensive patients treated for long periods with large doses of reserpine.

25 October 2022

59

1 reference

https://api.crossref.org/works/10.1016/0024-3205(78)90472-1

Antidepressants and the Muscarinic Acetylcholine Receptor

25 October 2022

60

1 reference

https://api.crossref.org/works/10.1016/0024-3205(78)90472-1

25 October 2022

Identifiers

1 reference

8 September 2017

1 reference